Andrew M. Weiss

Andrew joined us in 2023, bringing with him a wealth of experience in the medical devices sector, with expertise in device development, clinical and regulatory strategy, fund-raising, strategic business development, and team leadership.

As a Venture Partner, Andrew investigates global medical device investment opportunities across the Sofinnova Partners platform of strategies. He is currently on the board of May Health and SafeHeal, two companies in the portfolio of Sofinnova's medtech incubator strategy, MD Start.

"I share Sofinnova’s passion for finding, nurturing and bringing new medical device therapies to patients," Weiss said when he was appointed Venture Partner." Having worked both informally and as a portfolio company CEO with Sofinnova for the past 20 years, I know that they have the best team, and are the gold-standard medical device venture group."

In 2013, Andrew was brought in as CEO to lead ReCor Medical, a company founded in 2009 by Mano Iyer, then an entrepreneur in residence at Sofinnova and now a partner in the Sofinnova medtech acceleration team. Mr. Weiss led ReCor, a pioneer in the use of ultrasound renal denervation to treat hypertension, as it scaled up to 175 employees, went through its clinical trials and was purchased by Otsuka Medical Devices in 2018. Sofinnova Partners was the sole VC investor in ReCor at the time of the sale. Andrew stayed at the combined company until 2023, the year ReCor received FDA approval for its Renal Denervation System.

Before he took the reins at ReCor, Andrew held leadership roles including President & CEO of Vital Images (acquired by Toshiba), VP & General Manager of the Medtronic Surgical Navigation Systems and Neurological businesses, and President & CEO of CoAxia, which was sold to Zoll Medical.

Andrew has also been an advisor to and board member of a number of medical device companies in the US, Europe and Israel.

He is a graduate of the Massachusetts Institute of Technology with a degree in mechanical and electrical engineering and has an MBA from the Columbia University Graduate School of Business